THERAPY DOSSIER · th-04a2e49227f2

Natural latex serum 1% from Hevea brasiliensis in a gel-cream vehicle

Nutraceutical

Evidence & regulatory context

Mechanism: Not recorded
Target: Not recorded
Injury models: Wound
Reported indication: Not recorded
First approval: Not recorded
Development stage: Not recorded
ChEMBL record: Not recorded
ChEMBL max phase: Not recorded
Synonyms: Not recorded
Note: Not recorded

Clinical trials 0

0 linked trials carry an injury-indication flag. These flags support record-level exploration and sit alongside the stringent aggregate counts described in Methods.

No linked human trial in this dataset.

Preclinical evidence 1

1 studies reported at therapy level; 1 evidence entries itemised.

PMID 32473773 ↗2020Reported benefit

Healing effects of natural latex serum 1% from Hevea brasiliensis in an experimental skin abrasion wound model.

RatWoundWistarMalen = 72 rats in total, 24 per group, 8 euthanised per group on e…Topical, without occlusive dressingLatex serum 1% (gel-cream formulation)Treatment started after dermabrasion and given daily

Model: Dorsal cervical skin abrasion (dermabrasion) of approximately 2 cm made with an LB-100 dermabrader and diamond sanding disk

Latex serum 1% gave a higher re-epithelialisation rate than saline and antiseptic at day 7 and reached about 99% re-epithelialisation by day 10 versus 88% for antiseptic and 83% for saline, with thinner crusts and a thicker epidermis. Myeloperoxidase peaked at day 2 in all groups and fell from day…

Extraction: extract · Supplied extraction confidence: 0.9. Machine-extracted fields require source verification.

Loading the evidence…